CD44 and nonpapillary renal cell carcinoma: These results suggest that CD44 was up-regulated in ccRCC and had a positive correlation with unfavorable patient survival, potentially promoting ccRCC tumorigenesis by modulating cell-matrix interactions and ECM remodeling.